American Red Cross Blood Services, Alabama And Central Gulf Coast Region (ACGC)/Mobile Fixed Site FDA Inspection Record

FEI 1073005 · Inspections, Form 483s, warning letters and import refusals

American Red Cross Blood Services, Alabama And Central Gulf Coast Region (ACGC)/Mobile Fixed Site is an FDA-inspected facility (FEI 1073005) located in Mobile, AL, US. RegDataLab tracks 18 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Mar 28, 2023: No Action Indicated (NAI)
Inspections on record
18 (2 VAI, 16 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
11, latest Feb 14, 2003

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 18 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Mar 28, 2023No Action Indicated (NAI)No citations listed
Jul 22, 2019No Action Indicated (NAI)No citations listed
Aug 24, 2017No Action Indicated (NAI)No citations listed
Aug 21, 2017No Action Indicated (NAI)No citations listed
Jul 15, 2015No Action Indicated (NAI)No citations listed
Jul 15, 2015No Action Indicated (NAI)No citations listed
Jul 24, 2014No Action Indicated (NAI)No citations listed
Jul 24, 2014No Action Indicated (NAI)No citations listed
Sep 9, 2013Voluntary Action Indicated (VAI)No citations listed
Sep 9, 2013No Action Indicated (NAI)No citations listed

Recalls

Showing the 10 most recent of 11 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Feb 14, 2003Class IIB-0979-5Platelets, Pheresis, Leukocyte Reduced
Blood Product, collected from a donor whose health history screening did not include questioning regarding risk factors for new variant…
Dec 17, 2002Class IIB-1010-5Red Blood Cells, Leukocytes Reduced
Blood Products, collected from a donor who had previously tested reactive for hepatitis B, were distributed.
Feb 6, 2002Class IIB-0919-5Platelets, Pheresis, Leukoreduced
Blood product, with an unacceptably high platelet yield, was distributed.
Feb 5, 2002Class IIB-1002-5Platelets Pheresis, Leukocytes Reduced
Platelet Pheresis, in which the corresponding blood component was contaminated with coagulase-negative, Staphylococcus and implicated in a…
Dec 20, 2001Class IIB-0978-5Recovered Plasma
Blood product, collected from a donor considered to be at increased risk of exposure to new variant Creutzfeldt-Jakob Disease (nvCJD), was…
Nov 7, 2001Class IIB-0946-5Red Blood Cells, Leukoreduced
Blood product, collected from a donor whose arm preparation was inadequate, was distributed.
Jul 19, 2001Class IIB-0963-5Red Blood Cells, Leukoreduced
Blood product, collected from a donor who had lived in an area considered to be endemic for malaria, was distributed.
May 24, 2001Class IIB-1067-5Red Blood Cells
Blood product, which tested positive for syphilis, was distributed.
Jan 4, 2001Class IIB-0989-5Red Blood Cells, Leukocytes Reduced and 1 more product
Blood products, collected from a donor who had engaged in high risk behaviors, were distributed.
Dec 12, 2000Class IIB-1013-5Red Blood Cells and 1 more product
Blood Products, collected from a donor who had previously tested reactive for hepatitis C (HCV), were distributed.

FDA record score

0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

12 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAISep 9, 201310 years or older, so it adds no points0
Inspection classified VAIJun 28, 201210 years or older, so it adds no points0
Class II recall B-0979-5, this FEI as the recalling firmFeb 14, 200310 years or older, so it adds no points0
Class II recall B-1010-5, this FEI as the recalling firmDec 17, 200210 years or older, so it adds no points0
Class II recall B-0919-5, this FEI as the recalling firmFeb 6, 200210 years or older, so it adds no points0
Class II recall B-1002-5, this FEI as the recalling firmFeb 5, 200210 years or older, so it adds no points0
Class II recall B-0978-5, this FEI as the recalling firmDec 20, 200110 years or older, so it adds no points0
Class II recall B-0946-5, this FEI as the recalling firmNov 7, 200110 years or older, so it adds no points0
Class II recall B-0963-5, this FEI as the recalling firmJul 19, 200110 years or older, so it adds no points0
Class II recall B-1067-5, this FEI as the recalling firmMay 24, 200110 years or older, so it adds no points0
Class II recall B-0989-5, this FEI as the recalling firmJan 4, 200110 years or older, so it adds no points0
Class II recall B-1013-5, this FEI as the recalling firmDec 12, 200010 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing American Red Cross Blood Services, Alabama And Central Gulf Coast Region (ACGC)/Mobile Fixed Site as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check American Red Cross Blood Services, Alabama And Central Gulf Coast Region (ACGC)/Mobile Fixed Site yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Location
Mobile, AL (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.